CASI Pharmaceuticals, Inc. (CASI): Market Value

CASI Pharmaceuticals manages a commercial distribution network for oncology drugs in China, serving as a vital link for global pharmaceutical companies. The efficiency of biocomponent deliveries is ensured through streamlined aviation routes and regional hubs. The price action vector available for analysis on GURU.Markets, where the indicator stands at 0.00, confirms a strategy of expanding the licensed product portfolio to minimize patent risks.

CASI Pharmaceuticals, Inc. - CASI Market Capitalization (period 07/04/2022 - 03/14/2026)

Metric breakdowns and analytics for casipharmaceuticals.com (CASI)

- current price and projected stock value:

Stock Price CASI Pharmaceuticals, Inc.|CASI - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value CASI Pharmaceuticals, Inc|CASI - Company Buyout Price

- book value of equity indicators:

Book Value per Share CASI Pharmaceuticals|CASI - Book Valuation of Business|Market Capitalization to Book Value Ratio casipharmaceuticals.com|CASI - Cumulative Company Assets

- company liabilities and liquidity data:

Total Debt to Capital CASI Pharmaceuticals|CASI - Long-Term Debt to Capital|Short-Term Debt to Equity CASI Pharmaceuticals, Inc.|CASI - Company Aggregate Debt|Debts to Book Capitalization CASI Pharmaceuticals, Inc|CASI - Company Long-Term Liabilities|Company Short-Term Debts CASI Pharmaceuticals|Quick Liquidity casipharmaceuticals.com

- financial results and valuation multiples details:

CASI - Final Profit|Future Profit CASI Pharmaceuticals|CASI - Company Value to Net Income|Forward P/E Multiple CASI Pharmaceuticals, Inc.|CASI - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CASI Pharmaceuticals, Inc|CASI - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months CASI Pharmaceuticals|CASI - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months casipharmaceuticals.com|CASI - Earnings per share growth rate in current year|Earnings growth forecast for next year CASI Pharmaceuticals

Fundamental company valuation:CASI Pharmaceuticals, Inc CASI

Product sample of CASI Pharmaceuticals, Inc.

The valuation of CASI Pharmaceuticals (CASI) remains independent of market cycles, driven solely by the successful launch of oncology drugs in China. An analysis of the business's market capitalization allows for an assessment of the company's total equity value. This indicator measures the scale of the enterprise, identifying when the asset is overbought at historical peaks. Sharp fluctuations in this metric often signal speculative pressure. Understanding this trend protects investors from entering a position at an inflated price.

CASI Pharmaceuticals, Inc. (CASI): Market Value

Metric breakdowns and analytics for casipharmaceuticals.com (CASI)

Competitors of CASI Pharmaceuticals (CASI)